Heparin Market By Product (Ultra-low Molecular Weight Heparin (ULMWH), Unfractionated Heparin and Low Molecular Weight Heparin (LMWH)); Source (Porcine and Bovine); and Route of Administration (Parenteral and Oral); - Global Industry Analysis And Forecast To 2027
Published On : August 2018 Pages : 180 Category: Healthcare IT Report Code : HC081207
Industry Outlook
Heparin is a component that is found in liver and other tissues that deals with blood coagulation. Heparin has various applications related to; treatment of pulmonary clotting, avoiding blood clotting in dialysis procedure and prevention of blood clotting during open heart surgery. Heparin doses are the mostly consumed clinical anticoagulant over a period of year. The wide use of heparin is due to plus points like; being economical, instant action, simple laboratory observations, etc. heparin Market is showing growth due to increased number of surgical process and treatment of various disorders. Therefore, the Heparin Market is anticipated to expand and has tremendous scope during the forecast period. The global Heparin Market is anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Heparin Market is based on segment, by Product the market is segmented into Ultra-low Molecular Weight Heparin (ULMWH), Unfractionated Heparin and Low Molecular Weight Heparin (LMWH); by Source the market is segmented into Porcine and Bovine and by Route of Administration the market is segmented into Parenteral and Oral.
- Heparin Market, By Product
- Ultra-low Molecular Weight Heparin (ULMWH)
- Unfractionated Heparin
- Low Molecular Weight Heparin (LMWH)
- Heparin Market, By Source
- Porcine
- Bovine
- Heparin Market, By Route of Administration
- Parenteral
- Oral
Regional Insights
On a global front, the Heparin Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the global the Heparin Market, followed by European region.
Heparin Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Baxter International Inc., B. Braun Melsungen AG, Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, Aspen, Fresenius SE & Co. KGaA, Syntex S.A, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Sanofi. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Baxter International Inc.
- B. Braun Melsungen AG
- Dr. Reddy’s Laboratories Ltd.
- LEO Pharma A/S
- Aspen
- Fresenius SE & Co. KGaA
- Syntex S.A
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- SanofiSmith & Nephew
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Heparin Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Ultra-low Molecular Weight Heparin (ULMWH)
o Unfractionated Heparin
o Low Molecular Weight Heparin (LMWH)
o Heparin Market, By Source, Estimates and Forecast, 2017-2027 ($Million)
o Porcine
o Bovine
o Heparin Market, By Route of Administration, Estimates and Forecast, 2017-2027 ($Million)
o Parenteral
o Oral
o Heparin Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Heparin Market, By Country
o U.S. Heparin Market
o Canada Heparin Market
o Mexico Heparin Market
o Europe
§ Europe Heparin Market, By Country
o Germany Heparin Market
o UK Heparin Market
o France Heparin Market
o Russia Heparin Market
o Italy Heparin Market
o Rest of Europe Heparin Market
o Asia-Pacific
§ Asia-Pacific Heparin Market, By Country
o China Heparin Market
o Japan Heparin Market
o South Korea Heparin Market
o India Heparin Market
o Southeast Asia Heparin Market
o Rest of Asia-Pacific Heparin Market
o South America
§ South America Heparin Market, By Country
o Brazil Heparin Market
o Argentina Heparin Market
o Columbia Heparin Market
o Rest of South America Heparin Market
o Middle East and Africa
§ Middle East and Africa Heparin Market, By Country
o Saudi Arabia Heparin Market
o UAE Heparin Market
o Egypt Heparin Market
o Nigeria Heparin Market
o South Africa Heparin Market
o Rest of MEA Heparin Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2027)
4.1.2. Canada Market States and Outlook (2017-2027)
4.1.3. Mexico Market States and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2027)
4.2.2. France Market States and Outlook (2017-2027)
4.2.3. UK Market States and Outlook (2017-2027)
4.2.4. Russia Market States and Outlook (2017-2027)
4.2.5. Italy Market States and Outlook (2017-2027)
4.2.6. Rest of Europe Market States and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2027)
4.3.2. Japan Market States and Outlook (2017-2027)
4.3.3. Korea Market States and Outlook (2017-2027)
4.3.4. India Market States and Outlook (2017-2027)
4.3.5. Southeast Asia Market States and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2027)
4.4.2. Argentina Market States and Outlook (2017-2027)
4.4.3. Columbia Market States and Outlook (2017-2027)
4.4.4. Rest of South America Market States and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2027)
4.5.2. United Arab Emirates Market States and Outlook (2017-2027)
4.5.3. Egypt Market States and Outlook (2017-2027)
4.5.4. Nigeria Market States and Outlook (2017-2027)
4.5.5. South Africa Market States and Outlook (2017-2027)
4.5.6. Turkey Market States and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2027)
5. Heparin Market, By Product
5.1. Introduction
5.2. Global Heparin Revenue and Market Share by Product (2017-2027)
5.2.1. Global Heparin Revenue and Revenue Share by Product (2017-2027)
5.3. Ultra-low Molecular Weight Heparin (ULMWH)
5.3.1. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue and Growth Rate (2017-2027)
5.4. Unfractionated Heparin
5.4.1. Global Unfractionated Heparin Revenue and Growth Rate (2017-2027)
5.5. Low Molecular Weight Heparin (LMWH)
5.5.1. Global Low Molecular Weight Heparin (LMWH) Revenue and Growth Rate (2017-2027)
6. Heparin Market, By Source
6.1. Introduction
6.2. Global Heparin Revenue and Market Share by Source (2017-2027)
6.2.1. Global Heparin Revenue and Revenue Share by Source (2017-2027)
6.3. Porcine
6.3.1. Global Porcine Revenue and Growth Rate (2017-2027)
6.4. Bovine
6.4.1. Global Bovine Revenue and Growth Rate (2017-2027)
7. Heparin Market, By Route Of Administration
7.1. Introduction
7.2. Global Heparin Revenue and Market Share by Route Of Administration (2017-2027)
7.2.1. Global Heparin Revenue and Revenue Share by Route Of Administration (2017-2027)
7.3. Parenteral
7.3.1. Global Parenteral Revenue and Growth Rate (2017-2027)
7.4. Oral
7.4.1. Global Oral Revenue and Growth Rate (2017-2027)
8. Heparin Market, By Region
8.1. Introduction
8.2. Global Heparin Revenue and Market Share by Regions
8.2.1. Global Heparin Revenue by Regions (2017-2027)
8.3. North America Heparin by Countries
8.3.1. North America Heparin Revenue and Growth Rate (2017-2027)
8.3.2. North America Heparin Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Heparin by Countries
8.4.1. Europe Heparin Revenue and Growth Rate (2017-2027)
8.4.2. Europe Heparin Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Heparin by Countries
8.5.1. Asia-Pacific Heparin Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Heparin Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Heparin by Countries
8.6.1. South America Heparin Revenue and Growth Rate (2017-2027)
8.6.2. South America Heparin Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Heparin by Countries
8.7.1. Middle East and Africa Heparin Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Heparin Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Baxter International Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. B. Braun Melsungen AG
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Dr. Reddy’s Laboratories Ltd.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. LEO Pharma A/S
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Aspen
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Fresenius SE & Co. KGaA
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Syntex S.A
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Pfizer Inc.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Teva Pharmaceutical Industries Ltd.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. SanofiSmith & Nephew
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Heparin Market Competition, by Manufacturer
10.1. Global Heparin Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Heparin Price By Region (2017-2017)
10.3. Top 5 Heparin Manufacturer Market Share
10.4. Market Competition Trend
11. Heparin Market Forecast (2017-2027)
11.1. Global Heparin Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Heparin Market Forecast by Regions (2017-2027)
11.2.1. North America Heparin Market Forecast (2017-2027)
11.2.1.1. United States Heparin Market Forecast (2017-2027)
11.2.1.2. Canada Heparin Market Forecast (2017-2027)
11.2.1.3. Mexico Heparin Market Forecast (2017-2027)
11.2.2. Europe Heparin Market Forecast (2017-2027)
11.2.2.1. Germany Heparin Market Forecast (2017-2027)
11.2.2.2. France Heparin Market Forecast (2017-2027)
11.2.2.3. UK Heparin Market Forecast (2017-2027)
11.2.2.4. Russia Heparin Market Forecast (2017-2027)
11.2.2.5. Italy Heparin Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Heparin Market Forecast (2017-2027)
11.2.3. Asia-Pacific Heparin Market Forecast (2017-2027)
11.2.3.1. China Heparin Market Forecast (2017-2027)
11.2.3.2. Japan Heparin Market Forecast (2017-2027)
11.2.3.3. Korea Heparin Market Forecast (2017-2027)
11.2.3.4. India Heparin Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Heparin Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Heparin Market Forecast (2017-2027)
11.2.4. South America Heparin Market Forecast (2017-2027)
11.2.4.1. Brazil Heparin Market Forecast (2017-2027)
11.2.4.2. Argentina Heparin Market Forecast (2017-2027)
11.2.4.3. Columbia Heparin Market Forecast (2017-2027)
11.2.4.4. Rest of South America Heparin Market Forecast (2017-2027)
11.2.5. Middle East and Africa Heparin Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Heparin Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Heparin Market Forecast (2017-2027)
11.2.5.3. Egypt Heparin Market Forecast (2017-2027)
11.2.5.4. Nigeria Heparin Market Forecast (2017-2027)
11.2.5.5. South Africa Heparin Market Forecast (2017-2027)
11.2.5.6. Turkey Heparin Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Heparin Market Forecast (2017-2027)
11.3. Heparin Market Forecast by Product (2017-2027)
11.3.1. Heparin Forecast by Product (2017-2027)
11.3.2. Heparin Market Share Forecast by Product (2017-2027)
11.4. Heparin Market Forecast by Source (2017-2027)
11.4.1. Heparin Forecast by Source (2017-2027)
11.4.2. Heparin Market Share Forecast by Source (2017-2027)
11.5. Heparin Market Forecast by Route Of Administration (2017-2027)
11.5.1. Heparin Forecast by Route Of Administration (2017-2027)
11.5.2. Heparin Market Share Forecast by Route Of Administration (2017-2027)12.
List of Tables
List of Tables and Figures
Figure United States Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Heparin Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Heparin Revenue and Revenue Share by Product (2017-2018)
Figure Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue and Growth Rate (2017-2018)
Figure Global Unfractionated Heparin Revenue and Growth Rate (2017-2018)
Figure Global Low Molecular Weight Heparin (LMWH) Revenue and Growth Rate (2017-2018)
Table Global Heparin Revenue and Revenue Share by Source (2017-2018)
Figure Global Porcine Revenue and Growth Rate (2017-2018)
Figure Global Bovine Revenue and Growth Rate (2017-2018)
Table Global Heparin Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Parenteral Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Table Global Heparin Revenue by Regions (2017-2018)
Figure North America Heparin Growth Rate (2017-2018)
Figure North America Heparin Revenue and Growth Rate (2017-2018)
Figure North America Heparin by Countries (2017-2018)
Figure North America Heparin Revenue (Million USD) by Countries (2017-2018)
Figure United States Heparin Growth Rate (2017-2018)
Figure United States Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Heparin Growth Rate (2017-2018)
Figure Canada Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Heparin Growth Rate (2017-2018)
Figure Mexico Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Heparin Growth Rate (2017-2018)
Figure Europe Heparin Revenue and Growth Rate (2017-2018)
Figure Europe Heparin by Countries (2017-2018)
Figure Europe Heparin Revenue (Million USD) by Countries (2017-2018)
Figure Germany Heparin Growth Rate (2017-2018)
Figure Germany Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Heparin Growth Rate (2017-2018)
Figure France Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Heparin Growth Rate (2017-2018)
Figure UK Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Heparin Growth Rate (2017-2018)
Figure Russia Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Heparin Growth Rate (2017-2018)
Figure Italy Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Heparin Growth Rate (2017-2018)
Figure Rest of Europe Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Heparin Growth Rate (2017-2018)
Figure Asia-Pacific Heparin Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Heparin by Countries (2017-2018)
Figure Asia-Pacific Heparin Revenue (Million USD) by Countries (2017-2018)
Figure China Heparin Growth Rate (2017-2018)
Figure China Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Heparin Growth Rate (2017-2018)
Figure Japan Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Heparin Growth Rate (2017-2018)
Figure Korea Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Heparin Growth Rate (2017-2018)
Figure India Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Heparin Growth Rate (2017-2018)
Figure Southeast Asia Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Heparin Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Heparin Growth Rate (2017-2018)
Figure South America Heparin Revenue and Growth Rate (2017-2018)
Figure South America Heparin by Countries (2017-2018)
Figure South America Heparin Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Heparin Growth Rate (2017-2018)
Figure Brazil Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Heparin Growth Rate (2017-2018)
Figure Argentina Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Heparin Growth Rate (2017-2018)
Figure Columbia Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Heparin Growth Rate (2017-2018)
Figure Rest of South America Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Heparin Growth Rate (2017-2018)
Figure Middle East and Africa Heparin Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Heparin by Countries (2017-2018)
Figure Middle East and Africa Heparin Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Heparin Growth Rate (2017-2018)
Figure Saudi Arabia Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Heparin Growth Rate (2017-2018)
Figure United Arab Emirates Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Heparin Growth Rate (2017-2018)
Figure Egypt Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Heparin Growth Rate (2017-2018)
Figure Nigeria Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Heparin Growth Rate (2017-2018)
Figure South Africa Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Heparin Growth Rate (2017-2018)
Figure Turkey Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Heparin Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Heparin Revenue (Millions USD) and Growth Rate (2017-2018)
Table Baxter International Inc. Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table B. Braun Melsungen AG Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dr. Reddy’s Laboratories Ltd. Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table LEO Pharma A/S Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Aspen Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Fresenius SE & Co. KGaA Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Syntex S.A Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Teva Pharmaceutical Industries Ltd. Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Table SanofiSmith & Nephew Heparin Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Heparin Market Share by Manufacturer
Figure Global Heparin Revenue and Market Share by Manufacturer
Table Global Heparin Price by Region (2017-2017)
Figure Top 5 Heparin Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Heparin Revenue (Millions USD) and Growth Rate (2018-2025)
Table Heparin Market Forecast by Regions (2018-2025)
Figure North America Heparin Market Forecast (2018-2025)
Figure United States Heparin Market Forecast (2018-2025)
Figure Canada Heparin Market Forecast (2018-2025)
Figure Mexico Heparin Market Forecast (2018-2025)
Figure Europe Heparin Market Forecast (2018-2025)
Figure Germany Heparin Market Forecast (2018-2025)
Figure France Heparin Market Forecast (2018-2025)
Figure UK Heparin Market Forecast (2018-2025)
Figure Russia Heparin Market Forecast (2018-2025)
Figure Italy Heparin Market Forecast (2018-2025)
Figure Rest of Europe Heparin Market Forecast (2018-2025)
Figure Asia-Pacific Heparin Market Forecast (2018-2025)
Figure China Heparin Market Forecast (2018-2025)
Figure Japan Heparin Market Forecast (2018-2025)
Figure Korea Heparin Market Forecast (2018-2025)
Figure India Heparin Market Forecast (2018-2025)
Figure Southeast Asia Heparin Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Heparin Market Forecast (2018-2025)
Figure South America Heparin Market Forecast (2018-2025)
Figure Brazil Heparin Market Forecast (2018-2025)
Figure Argentina Heparin Market Forecast (2018-2025)
Figure Columbia Heparin Market Forecast (2018-2025)
Figure Rest of South America Heparin Market Forecast (2018-2025)
Figure Middle East and Africa Heparin Market Forecast (2018-2025)
Figure Saudi Arabia Heparin Market Forecast (2018-2025)
Figure United Arab Emirates Heparin Market Forecast (2018-2025)
Figure Egypt Heparin Market Forecast (2018-2025)
Figure Nigeria Heparin Market Forecast (2018-2025)
Figure South Africa Heparin Market Forecast (2018-2025)
Figure Turkey Heparin Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Heparin Market Forecast (2018-2025)
Figure Global Heparin Forecast by Product (2018-2025)
Figure Global Heparin Market Share Forecast by Product (2018-2025)
Figure Global Heparin Forecast by Product (2018-2025)
Figure Global Heparin Forecast by Source (2018-2025)
Figure Global Heparin Market Share Forecast by Source (2018-2025)
Figure Global Heparin Forecast by Source (2018-2025)
Figure Global Heparin Forecast by Route Of Administration (2018-2025)
Figure Global Heparin Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Heparin Forecast by Route Of Administration (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|